R.W. Roge & Company’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$378K Sell
1,547
-9
-0.6% -$2.1K 0.18% 45
2025
Q4
$321K Buy
1,556
+114
+8% +$22.5K 0.16% 49
2025
Q3
$267K Buy
1,442
+34
+2% +$5.83K 0.14% 50
2025
Q2
$215K Sell
1,408
-190
-12% -$29.2K 0.12% 52
2025
Q1
$265K Sell
1,598
-38
-2% -$5.95K 0.15% 46
2024
Q4
$236K Hold
1,636
0.13% 44
2024
Q3
$265K Buy
1,636
+38
+2% +$6.05K 0.14% 41
2024
Q2
$233K Hold
1,598
0.13% 38
2024
Q1
$253K Hold
1,598
0.15% 36
2023
Q4
$250K Hold
1,598
0.16% 36
2023
Q3
$232K Hold
1,598
0.17% 39
2023
Q2
$264K Hold
1,598
0.18% 34
2023
Q1
$247K Hold
1,598
0.16% 35
2022
Q4
$282K Hold
1,598
0.19% 32
2022
Q3
$260K Hold
1,598
0.18% 30
2022
Q2
$284K Hold
1,598
0.19% 30
2022
Q1
$283K Hold
1,598
0.2% 34
2021
Q4
$263K Hold
1,598
0.2% 34
2021
Q3
$262K Buy
1,598
+200
+14% +$34.1K 0.16% 33
2021
Q2
$237K Hold
1,398
0.15% 34
2021
Q1
$230K Hold
1,398
0.16% 34
2020
Q4
$220K Hold
1,398
0.16% 35
2020
Q3
$212K Buy
+1,398
New +$207K 0.16% 33
2020
Q1
Sell
-1,657
Closed -$239K 39
2019
Q4
$239K Buy
+1,657
New +$225K 0.24% 41

Other funds holding JNJ

R.W. Roge & Company's JNJ Position: Q1 2026 in Review

R.W. Roge & Company reduced its Johnson & Johnson (JNJ) stake by 0.58% in Q1 2026, selling an estimated $2.1K and leaving 1,547 shares worth $378K. The position accounts for 0.18% of the portfolio, ranked #45.

R.W. Roge & Company first reported a position in JNJ in Q4 2019 and has held it in 24 quarters since. 4,617 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • R.W. Roge & Company held 1,547 shares of Johnson & Johnson worth $378K as of Q1 2026.
  • R.W. Roge & Company sold 9 Johnson & Johnson shares in Q1 2026, an estimated $2.1K.
  • Johnson & Johnson made up 0.18% of R.W. Roge & Company's portfolio in Q1 2026, its #45 holding.
  • R.W. Roge & Company first reported a position in Johnson & Johnson in Q4 2019 and has held it in 24 quarters since.
  • 4,617 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on R.W. Roge & Company's 13F filing for Q1 2026, filed 1 May 2026.